Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.24.1.1.u2
Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 48,930 $ 9,701
Prepaid expenses and other current assets 2,746 3,698
Total current assets 51,676 13,399
Right of use asset, net 686 766
Property, plant and equipment, net 23 26
Total assets 52,385 14,191
Current liabilities:    
Accounts payable 1,240 839
Accrued liabilities 3,550 3,234
Dividends payable 208
Warrant liability 24,941 13,134
Operating lease liability - current 343 327
Total current liabilities 30,282 17,534
Operating lease liability – long term 372 466
Total liabilities 30,654 18,000
Commitments and contingencies (Note 8)
Stockholders’ deficit:    
Preferred stock value
Common stock, $0.001 par value per share – 200,000,000 shares authorized at December 31, 2023 and March 31, 2024; 34,756,049 and 37,606,630 shares issued and outstanding at December 31, 2023 and March 31, 2024, respectively 37 35
Additional paid-in capital 61,011 60,697
Accumulated deficit (85,504) (64,541)
Total stockholders’ deficit (24,456) (3,809)
Total liabilities and stockholders’ deficit 52,385 14,191
Series B-1 preferred stock    
Mezzanine equity:    
Series B-1 preferred stock, $0.001 par value per share – zero shares authorized at December 31, 2023, and 50,000 shares authorized at March 31, 2024; zero shares outstanding at December 31, 2023, and 50,000 shares outstanding at March 31, 2024 46,187
Series A-2 preferred stock    
Stockholders’ deficit:    
Preferred stock value